Wells Fargo
JBIO

Wells Fargo’s Jade Biosciences JBIO Stock Holding History

Wells Fargo’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$660K Buy
29,721
+17,675
+147% +$369K ﹤0.01% 4414
2026
Q1 		$169K Sell
12,046
-39,846
-77% -$577K ﹤0.01% 4805
2025
Q4 		$801K Buy
51,892
+27,022
+109% +$317K ﹤0.01% 4134
2025
Q3 		$215K Buy
24,870
+4,037
+19% +$33K ﹤0.01% 4898
2025
Q2 		$208K Buy
20,833
+20,628
+10,062% +$702K ﹤0.01% 4745
2025
Q1 		$18K Buy
205
+4
+2% +$351 ﹤0.01% 5743
2024
Q4 		$18.7K Buy
201
+61
+44% +$5.26K ﹤0.01% 5786
2024
Q3 		$10.2K Sell
140
-5
-3% -$323 ﹤0.01% 5794
2024
Q2 		$8.4K Buy
145
+49
+51% +$32.5K ﹤0.01% 5787
2024
Q1 		$99.4K Buy
96
+13
+16% +$9.93K ﹤0.01% 4900
2023
Q4 		$65.9K Buy
83
+19
+30% +$9.68K ﹤0.01% 5155
2023
Q3 		$30.6K Sell
64
-56
-47% -$30.3K ﹤0.01% 5425
2023
Q2 		$72K Buy
120
+73
+155% +$46.7K ﹤0.01% 5226
2023
Q1 		$33K Buy
+47
New +$39K ﹤0.01% 5392
2022
Q4 		– Sell
-1
Closed – – 7461
2022
Q3 		$0 Sell
1
-2
-67% -$1.33K ﹤0.01% 6642
2022
Q2 		$2K Sell
3
-40
-93% -$19.1K ﹤0.01% 6291
2022
Q1 		$27K Sell
43
-85
-66% -$33K ﹤0.01% 5900
2021
Q4 		$52K Buy
128
+126
+6,300% +$63.7K ﹤0.01% 5948
2021
Q3 		$1K Buy
+2
New +$1.12K ﹤0.01% 6653

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wells Fargo's JBIO Position: Q2 2026 in Review

Wells Fargo increased its Jade Biosciences (JBIO) stake by 147% in Q2 2026, buying an estimated $369K and bringing the position to 29,721 shares worth $660K. The position accounts for ﹤0.01% of the portfolio, ranked #4414.

Wells Fargo first reported a position in JBIO in Q3 2021 and has held it in 19 quarters since. The position peaked at $801K in Q4 2025. 153 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Wells Fargo held 29,721 shares of Jade Biosciences worth $660K as of Q2 2026.
  • Wells Fargo bought 17,675 Jade Biosciences shares in Q2 2026, an estimated $369K.
  • Jade Biosciences made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4414 holding.
  • Wells Fargo first reported a position in Jade Biosciences in Q3 2021 and has held it in 19 quarters since.
  • Wells Fargo's Jade Biosciences position peaked at $801K in Q4 2025.
  • 153 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.